FUJIFILM RI Pharma begins phase II studies of F-1641 for refractory pheochromocytoma in Japan Feb. 20, 2018
FDA grants de novo request for commercialization of Banyan BTI test for traumatic brain injury Feb. 15, 2018
Cancer Targeted Technology, Advanced Accelerator Applications enter CTT-1057 license agreement Feb. 13, 2018
RSS